Psoralen plus ultraviolet‐A‐bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease

Abstract

Psoralen plus ultraviolet-A-bath represents an effective adjunct treatment option for extensive chronic and sclerodermic cutaneous GVHD offered by dermatologists. This is of high interest in patients suffering from cutaneous GVHD resistant to conventional immunosuppressive therapy and should be included to the menu of topical treatment options for chronic cutaneous GVHD.